Pyratine-6™ Reduces Erythema
 

 
 

Clinical Study1 Highlights:

  • Pyratine-6™ doesn’t cause redness; it rapidly reduces redness

  • First known study to show reduced erythema associated with the use of a topical cosmeceutical product

  • Pyratine-6™ showed improvement in pre-existing redness associated with various skin conditions, including rosacea, eczema, contact dermatitis and menopause

  • Facial erythema was reduced by 42% at week 2, 62% by week 4 and 67% by week 12

  • 45% decrease in acne lesions count was noted

 
 

 


baseline
 
week 2
 
52-year-old female at baseline, after 2 weeks of treatment with
Pyratine-6™ showing decrease in facial erythema.


 

 
  CONTACT US   |   TERMS OF USE   |   PRIVACY POLICY

© 2010 Senetek PLC.  All Rights Reserved.
Pyratine-6™ is a trademark of Senetek PLC